Mr. Lahr joined AusculSciences (then SonoMedica, Inc.) in 2007 as President and Chief Operating Officer and is responsible for developing the Company’s strategic direction, clinical focus, corporate structure, and management team. Prior to joining AusculSciences, Michael was a Managing Director at the Blackstone Group L.P. specializing in Corporate Restructuring and Reorganization where he worked extensively with senior management of major financially distressed companies to develop and implement company business plans and financial projections, manage cash liquidity, assist in strategic issues, raise alternative debt and equity financing and develop management retention and severance programs. Some of Mr. Lahr’s clients included Global Crossing Inc., Chiquita Brands International, The Singer Company N.V., Smarte Carte Inc., and American Banknote Corporation. Michael has also provided testimony in Federal Court on issues of business plan feasibility, valuation and sales processes.
Prior to Blackstone, Michael was in the corporate finance group of Lazard Brothers & Co. (London) working in a variety of areas including mergers and acquisitions, stock market flotations and strategic advisory assignments. Michael graduated from the University of Rochester with a B.S. in Biochemistry. Post-graduation, he spent one year as an honorary Middle Common Room member at St. Peters College, Oxford University studying economics and languages. He returned to Rochester to earn his M.B.A. in finance and international management from the William E. Simon Graduate School of Business Administration in 1993.